NEW ORLEANS, LA – Biotechnology is an area of medicine that has shown great promise in the last decade. Orthopaedic surgeons, researchers and scientists have been using stem cells, tissue engineering, bone marrow and gene therapy to treat disabling conditions, including fractures and bone defects. The American Academy of Orthopaedic Surgeons (AAOS) at its 2010 Annual Meeting will host a media briefing on Thursday, March 11, 2010, from 10:45 a.m. to 11:15 a.m. in Room 206 of the Morial Convention Center, to explore the future of biotechnology.
“In the last decade, there has been a lot of excitement with the development of these new procedures and technologies,” said Thomas Einhorn, MD, who will serve as the briefing moderator. “This new decade is really about pushing the envelope on research and determining if these new technologies are effective. We need to focus on designing really well thought out clinical trials for evaluating their true efficacy, effectiveness and safety.”
Young Lae Moon, MD, an associate professor in the orthopaedic department at Chosun University Hospital in Gwangju, Korea, will discuss at the briefing his research on the efficacy of injecting autologous (where the donor and recipient are the same person) bone marrow plasma after an arthroscopic repair of a rotator cuff tear. Dr. Moon found that in 28 patients with the autologous bone marrow plasma injection, their mobility and function in the shoulder was significantly better than the 28 patients who only had the initial repair. Read the abstract.
Additional panelists include Scott Boden, MD; Johnny Huard, Ph.D.; and Scott Rodeo, MD; who will discuss the following topics:
- use of bone morphogenetic proteins (BMPs) in spine surgery and trauma settings;
- an update on gene therapy and hurdles to application;
- how new technologies, such as platelet-rich plasma, enhance the healing of soft tissue injuries; and
- stem cell technology and orthopaedic tissue regeneration.
For more information, contact: